Chinese General Practice ›› 2023, Vol. 26 ›› Issue (24): 3016-3021.DOI: 10.12114/j.issn.1007-9572.2023.0051
• Original Research • Previous Articles Next Articles
Received:
2023-01-09
Revised:
2023-02-26
Published:
2023-08-20
Online:
2023-04-15
Contact:
LI Xia
通讯作者:
李霞
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0051
冠状动脉狭窄程度 | 权重系数 | 狭窄程度 | 评分(分) |
---|---|---|---|
左主干病变 | 5.0 | 1%~25% | 1 |
左前降支近段、回旋支近段病变 | 2.5 | 26%~50% | 2 |
前降支中段病变 | 1.5 | 51%~75% | 4 |
前降支远段、回旋支中段、回旋支远段病变 | 1.0 | 76%~90% | 8 |
左心室后侧支、钝缘支动脉、第一对角支、心尖支病变 | 1.0 | 91%~99% | 16 |
右冠状动脉病变 | 1.0 | 100% | 32 |
第二对角支病变 | 0.5 |
Table 1 Corresponding table of coronary stenosis severity and weight coefficient
冠状动脉狭窄程度 | 权重系数 | 狭窄程度 | 评分(分) |
---|---|---|---|
左主干病变 | 5.0 | 1%~25% | 1 |
左前降支近段、回旋支近段病变 | 2.5 | 26%~50% | 2 |
前降支中段病变 | 1.5 | 51%~75% | 4 |
前降支远段、回旋支中段、回旋支远段病变 | 1.0 | 76%~90% | 8 |
左心室后侧支、钝缘支动脉、第一对角支、心尖支病变 | 1.0 | 91%~99% | 16 |
右冠状动脉病变 | 1.0 | 100% | 32 |
第二对角支病变 | 0.5 |
组别 | 例数 | 年龄(岁) | 性别(男/女) | 吸烟史〔例(%)〕 | BMI (kg/m2) | TC (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | TG (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
A组 | 50 | 63.2±10.1 | 22/28 | 13(26.0) | 25.3±2.9 | 4.27±1.11 | 2.58±0.96 | 1.51±0.28 | 1.77±1.27 |
B组 | 30 | 62.4±11.2 | 7/23 | 11(33.3) | 24.9±3.2 | 4.12±1.14 | 2.60±0.98 | 1.41±0.29 | 1.77±1.03 |
C组 | 30 | 62.1± 5.9 | 9/21 | 7(21.2) | 26.0±4.1 | 4.54±1.06 | 2.84±0.87 | 1.59±0.37 | 1.77±1.05 |
F(χ2)值 | 1.659 | 14.02 | 1.270a | 0.862 | 1.131 | 0.809 | 2.277 | 0.109 | |
P值 | 0.195 | 0.001 | 0.530 | 0.425 | 0.326 | 0.448 | 0.108 | 0.897 | |
组别 | Glu (mmol/L) | WBC (×109/L) | HR (次/min) | 高血压〔例(%)〕 | 糖尿病〔例(%)〕 | LVEF (%) | 收缩压(mmHg) | 舒张压(mmHg) | |
A组 | 7.08±2.59 | 6.75±1.73 | 76±13 | 38(51.4) | 19(38.0) | 64.38±5.83 | 134±20 | 81±10 | |
B组 | 7.83±3.70 | 6.85±1.69 | 76±13 | 23(31.1) | 14(46.6) | 61.10±7.33 | 129±19 | 74±14 | |
C组 | 6.11±2.20 | 5.98±1.25 | 81±16 | 13(17.6) | 8(26.7) | 65.10±4.77 | 131±20 | 82±14 | |
F(χ2)值 | 2.764 | 2.943 | 1.486 | 10.74a | 0.688a | 3.916 | 0.499 | 3.694 | |
P值 | 0.068 | 0.057 | 0.231 | 0.005 | 0.335 | 0.023 | 0.690 | 0.028 |
Table 2 Comparison of baseline data among the three groups
组别 | 例数 | 年龄(岁) | 性别(男/女) | 吸烟史〔例(%)〕 | BMI (kg/m2) | TC (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | TG (mmol/L) |
---|---|---|---|---|---|---|---|---|---|
A组 | 50 | 63.2±10.1 | 22/28 | 13(26.0) | 25.3±2.9 | 4.27±1.11 | 2.58±0.96 | 1.51±0.28 | 1.77±1.27 |
B组 | 30 | 62.4±11.2 | 7/23 | 11(33.3) | 24.9±3.2 | 4.12±1.14 | 2.60±0.98 | 1.41±0.29 | 1.77±1.03 |
C组 | 30 | 62.1± 5.9 | 9/21 | 7(21.2) | 26.0±4.1 | 4.54±1.06 | 2.84±0.87 | 1.59±0.37 | 1.77±1.05 |
F(χ2)值 | 1.659 | 14.02 | 1.270a | 0.862 | 1.131 | 0.809 | 2.277 | 0.109 | |
P值 | 0.195 | 0.001 | 0.530 | 0.425 | 0.326 | 0.448 | 0.108 | 0.897 | |
组别 | Glu (mmol/L) | WBC (×109/L) | HR (次/min) | 高血压〔例(%)〕 | 糖尿病〔例(%)〕 | LVEF (%) | 收缩压(mmHg) | 舒张压(mmHg) | |
A组 | 7.08±2.59 | 6.75±1.73 | 76±13 | 38(51.4) | 19(38.0) | 64.38±5.83 | 134±20 | 81±10 | |
B组 | 7.83±3.70 | 6.85±1.69 | 76±13 | 23(31.1) | 14(46.6) | 61.10±7.33 | 129±19 | 74±14 | |
C组 | 6.11±2.20 | 5.98±1.25 | 81±16 | 13(17.6) | 8(26.7) | 65.10±4.77 | 131±20 | 82±14 | |
F(χ2)值 | 2.764 | 2.943 | 1.486 | 10.74a | 0.688a | 3.916 | 0.499 | 3.694 | |
P值 | 0.068 | 0.057 | 0.231 | 0.005 | 0.335 | 0.023 | 0.690 | 0.028 |
组别 | 例数 | Egr3 | IL-6 |
---|---|---|---|
A组 | 50 | 1 587.74±889.96a | 43.05±18.76b |
B组 | 30 | 1 942.59±1 100.37a | 51.43±15.09a |
C组 | 30 | 1 116.11±624.56 | 39.65±15.47 |
F值 | 6.490 | 3.661 | |
P值 | 0.002 | 0.023 |
Table 3 Comparison ofEgr3 and IL-6 expressionlevels among three groups
组别 | 例数 | Egr3 | IL-6 |
---|---|---|---|
A组 | 50 | 1 587.74±889.96a | 43.05±18.76b |
B组 | 30 | 1 942.59±1 100.37a | 51.43±15.09a |
C组 | 30 | 1 116.11±624.56 | 39.65±15.47 |
F值 | 6.490 | 3.661 | |
P值 | 0.002 | 0.023 |
变量 | B | SE | t值 | P值 | 95%CI |
---|---|---|---|---|---|
常量 | 2 687.509 | 1 126.947 | 2.385 | 0.020 | (440.981,4 934.037) |
IL-6 | 21.333 | 5.018 | 4.251 | <0.001 | (11.330,31.336) |
Gensini评分 | 5.123 | 2.061 | 2.486 | 0.015 | (1.015,9.231) |
高血压 | 160.303 | 211.032 | 0.760 | 0.450 | (-260.381,580.987) |
LVEF | -23.235 | 13.974 | -1.663 | 0.101 | (-51.092,4.621) |
舒张压 | -11.907 | 7.653 | -1.556 | 0.124 | (-27.162,3.348) |
Table 4 Multivariate linear regressionmodel of Egr3 leveland related indicators
变量 | B | SE | t值 | P值 | 95%CI |
---|---|---|---|---|---|
常量 | 2 687.509 | 1 126.947 | 2.385 | 0.020 | (440.981,4 934.037) |
IL-6 | 21.333 | 5.018 | 4.251 | <0.001 | (11.330,31.336) |
Gensini评分 | 5.123 | 2.061 | 2.486 | 0.015 | (1.015,9.231) |
高血压 | 160.303 | 211.032 | 0.760 | 0.450 | (-260.381,580.987) |
LVEF | -23.235 | 13.974 | -1.663 | 0.101 | (-51.092,4.621) |
舒张压 | -11.907 | 7.653 | -1.556 | 0.124 | (-27.162,3.348) |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
李霞,王枚,马依彤,等. 新疆维吾尔族、哈萨克族、汉族冠心病差异基因筛选及功能路径分析[J]. 中国动脉硬化杂志,2016,24(12):1238-1242.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[1] | ZHANG Di, LI Hongpeng, MA Jiang, NIE Qian, SUN Jianfeng, WU Zhipeng, ZHANG Hongcai, ZHAO Jue. Effect of Ocular Acupuncture and Exercise Combination Therapy on Postoperative Heart Rate Variability and Prognosis of Patients Treated with Percutaneous Coronary Intervention [J]. Chinese General Practice, 2023, 26(36): 4535-4544. |
[2] | LUO Weigang, YIN Yuanyuan, LIU Wanhu, XU Yuzhu, CAO Xiaoyun, BU Wei, ZHANG Lingyan, REN Huiling. Correlation of Triglyceride Glucose Index with Early Neurological Deterioration in Patients with Single Subcortical Infarction [J]. Chinese General Practice, 2023, 26(35): 4419-4424. |
[3] | LAN Yonghao, KE Erqin, HAN Rui, MEI Yingchen, LIU Wei. Percutaneous Coronary Intervention via Distal Transradial Approach: Strengths, Weaknesses, Opportunities and Challenges [J]. Chinese General Practice, 2023, 26(27): 3355-3360. |
[4] | CHEN Weixiang, YIN Renlin, LING Lin, ZHANG Chi, JIANG Tingbo, LIN Jia. Correlation between C-reactive Protein to Albumin and Coronary Collateral Circulation in Patients with Unstable Angina Pectoris [J]. Chinese General Practice, 2023, 26(27): 3430-3434. |
[5] | YUAN Mingpei, LIN Yaowang, BEI Weijie, LIU Huadong, DONG Shaohong, SUN Xin. Feasibility of Retrograde Recanalization of Occluded Radial Artery via Distal Transradial Artery Approach: a Single-center Prospective Study [J]. Chinese General Practice, 2023, 26(27): 3373-3377. |
[6] | CAI Gaojun, SHI Ganwei, LI Feng, LI Wenhua, YAN Yongmin, XUE Sheliang, XIAO Jianqiang, GU Jun, SONG Yanbin, ZHANG Liuyan, LU Wei, GONG Chun. How to Improve the Success Puncture Rate of Distal Transradial Artery Approach, "Winding Path to the Secluded": Summary of the Experience of More than 2 000 Cases [J]. Chinese General Practice, 2023, 26(27): 3361-3365. |
[7] | LIU Minghao, WANG Pan, GAO Lijian, XU Shuqing, WANG Huanhuan, ZHAO Guangxian, CHEN Jue, QIAO Shubin, XU Bo, YUAN Jinqing. Feasibility, Safety and Timing of Secondary Percutaneous Coronary Intervention via Distal Transradial Artery Approach [J]. Chinese General Practice, 2023, 26(27): 3366-3372. |
[8] | YAN Haihao, ZHANG Feifei, DANG Yi. Correlation of Remnant Cholesterol with Vulnerable Plaque Characteristics in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2023, 26(26): 3303-3307. |
[9] | DING Xiaoyun, JIN Juzhen, YANG Jin, ZHOU Jing, HU Jin, MENG Yue, LIANG Xiaoxian, GAI Yun, WANG Junhua, WANG Ziyun. The Mediating Effect of Waist Circumference and Fasting Plasma Glucose on the Association between Obstructive Sleep Apnea Syndrome and Arterial Stiffness in a Population Aged 40-65 Years [J]. Chinese General Practice, 2023, 26(21): 2597-2602. |
[10] | WANG Dan, WANG Jianhui, DONG Jianxiu, CHANG Wenhong, QIN Lu, LIU Qi, CHEN Chen. Effect of an Internet-based Intervention on Motor Behavior in Patients after Percutaneous Coronary Intervention [J]. Chinese General Practice, 2023, 26(21): 2603-2608. |
[11] | ZHOU Shiyu, CHEN Shaolin, DENG Renli, DAI Mi, LIU Tao, TIAN Kunming. The Association and Predictive Value of Lipid Ratios to Metabolic Syndrome: a Multistage Cross-sectional Study [J]. Chinese General Practice, 2023, 26(21): 2589-2596. |
[12] | LIU Jingtao, SU He, QIN Xiaojin, LAN Yunxia, ZHANG Jinzhi. Guidelines on Cardiac Rehabilitation in Patients with Coronary Heart Disease: a Systematic Review [J]. Chinese General Practice, 2023, 26(19): 2323-2331. |
[13] | GAO Yang, WANG Yunxia, GAO Chuanyu. Familial Hypercholesterolemia in 45-year-old and Younger Patients with Acute Coronary Syndrome: Clinical Characteristics and Influencing Factors of Blood Lipid Control Effect [J]. Chinese General Practice, 2023, 26(18): 2232-2237. |
[14] | XU Bixia, YAO Weiguang. Changes in Patient Visits and Associated Determinants in Primary Healthcare Settings in Guangdong: a Grey Relational Analysis [J]. Chinese General Practice, 2023, 26(16): 1965-1971. |
[15] | DONG Linrui, CHANG Qingqing, MA Jianjun, LIU Chuanze, GUO Dashuai, LI Xiaohuan, FAN Yongyan, LI Dongsheng. Correlation between Autonomic Dysfunction and Cognitive Impairment in Patients with Parkinson's Disease [J]. Chinese General Practice, 2023, 26(12): 1450-1455. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||